ANTIDIABETIC ACTIVITY, ALPHA-AMYLASE AND ALPHA- GLUCOSIDASE INHIBITORY EFFECT OF PASTINACA SATIVA EXTRACT

J, Nagaraju; A, Rajasekhar Reddy; Raju  R, Subhakar; Rao  GSN, Koteswara; DSNBK, Prasanth; G, Chakravarthi

doi:10.21608/bfsa.2021.207157

ANTIDIABETIC ACTIVITY, ALPHA-AMYLASE AND ALPHA- GLUCOSIDASE INHIBITORY EFFECT OF PASTINACA SATIVA EXTRACT

Document Type : Original Article

Authors

¹ K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur, Andhra Pradesh, India 522 502

² Department of Pharmacology, Balaji Institute of Pharmaceutical Sciences, Laknepally, Narsampet, Warangal, Telangana, India 506331

10.21608/bfsa.2021.207157

Abstract

Pastinaca sativa belonging to the family Apiaceae, is a tropical tree used in many
countries as a herbal drug for the care of diabetic patients. However, the methodical rationale
for this medical use is very limited. The aim of this analysis was to examine the antidiabetic
activity of the Pastinaca sativa methanolic extract and the possible mechanisms underlying that
activity. The extract hypoglycemic behavior was investigated in typical diabetic rats induced
with alloxan. Finally, an effect of the Pastinaca sativa extract (Crude extract of Pastinaca
sativa-CEPS) on the activity of α-amylase and α-glucosidase was examined in vitro. CEPS
showed IC50 equal to 91.69 ± 1.5 μg/mL for α-amylase enzyme inhibition activity. Normal
acarbose (control) demonstrated IC50 equal to 83.25 ± 1.28 μg/mL. CEPS displayed IC50
values of 88.05 ± 1.25 μg/mL for α-glucosidase enzyme. Under similar laboratory conditions,
acarbose displayed an IC50 value of 51.00 ± 1.23 μg/mL. CEPS exhibited IC50 less than
100μg/mL would be considered as healthy. The extract at 400 mg/kg greatly decreased the
region under the blood glucose level curve in a typical rats test for oral glucose tolerance. A
single dose of the extract decreased significantly in the alloxan-induced diabetic model, similar
to glibenclamide (standard), from 208.33 mg/dl to 106.38 mg/dl at 200 mg/kg CEPS and from
209.82 mg/dl to 111.65 mg/dl at 400 mg/kg CEPS. These findings were comparable with 0.5
mg/kg of glibenclamide indicating a substantial decrease from 205.55 mg/dl on 7th day to
84.88 mg/dl. The Pastinaca sativa methanolic extract possesses strong antidiabetic activity in
vivo. Besides, the extract has also been shown to have a significant inhibitory activity of α-
amylase and α-glucosidase, which might lead to its anti-hyperglycemic function when used in
diabetic patients.